ArticleLeukemia2020

Good prognosis or poor prognosis, dose-intensive or less intensive: who decides for adults with T-lymphoblastic lymphoma/leukemia.

Ken H YoungPubMed ↗Publisher ↗

No numbers read from the abstract.